APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells
Pancreatic cancer (PC) is a disease with a high mortality rate, and the early diagnosis of PC is still challenging. The 5-year relative survival rate remains below 8%, and therapeutic strategies are ineffective at increasing patient survival rates. In PC cells, resistance to treatment has been asso...
Saved in:
| Main Authors: | Ali Haider Alhammer, Shaymaa Ismael Al-juboori, Shahad Ali Mudhafar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad, College of Science for Women
2024-08-01
|
| Series: | مجلة بغداد للعلوم |
| Subjects: | |
| Online Access: | https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/10135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
by: Sophia Ceder, et al.
Published: (2020-12-01) -
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
by: Vid Mlakar, et al.
Published: (2024-12-01) -
Diacylglycerol Kinase ζ Attenuates Doxorubicin‐Induced Cardiotoxicity Through p53 Degradation
by: Shingo Tachibana, et al.
Published: (2025-01-01) -
Metabolic transformation of 2,4,6-trichloroanisole in grass carp larvae: implications for morphological development and locomotor behavioral effects
by: Yanxia Zuo, et al.
Published: (2025-09-01) -
The impact of microplastics on the adsorption of 2,4,6-tribromophenol in soils: Competitive adsorption
by: Guoyu Ding, et al.
Published: (2025-07-01)